Congress Materials – Advances in Inflammatory Bowel Diseases (AIBD 2025)
2025 Advances in Inflammatory Bowel Diseases | Dec 8-10 | Orlando, FL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Unsupervised Machine Learning to Identify Distinct Response Patterns to Guselkumab in Participants With Crohn’s Disease: Post Hoc Analysis of the Pooled GRAVITI and GALAXI 2/3 Studies
Parambir S. Dulai, Geert D’Haens, Walter Reinisch, Ailsa Hart, Sudheer Rani, Mobolaji Olurinde, Rian Van Rampelbergh, Long-Long Gao, Zijiang Yang, Timothy Hoops, Chandni Valiathan, Stefan Schreiber
This document will be available on December 10th 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
